ALS Canada – Brain Canada Career Transition Award 2023
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire within unit
Memorial Deadline: Friday 18th, August 2023
External Deadline: Wednesday 23rd, August 2023
Description
Brain Canada and the ALS Society of Canada are pleased to announce the launch of the 2023 Career Transition Award. This program will identify and engage rising stars pursuing innovative research in labs and academic institutions in Canada. The Career Transition Award has the long-term goal of developing the next generation of scientists across various disciplines within basic and clinical sciences, contributing to knowledge generation and translation in ALS.
ALS Canada and Brain Canada will provide a three (3) year award to support a talented young investigator to pursue advanced research and transition into a junior faculty position at a Canadian institution. The award will be for up to three (3) years for a total of $250,000 CAD. Each year, ALS Canada and Brain Canada will provide a $60,000 salary and $20,000 research allowance, with $30,000 for research allowance in year three.
Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada is committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.
Please refer to the Terms of Reference for additional details.
Deadline for receipt of Full Applications: August 23, 2023 (1:00 pm ET)
This program has been made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the Government of Canada (through Health Canada) Brain Canada Foundation, and the ALS Society of Canada.
Important Dates
• Call announced June 28, 2023
• Application deadline August 23, 2023 (1:00 pm ET)
• Notification of award November 2023
• Funding begins January 2024